Arkis BioSciences
Medical device company providing minimally invasive surgical instrumentation and advanced implantable technology.
Launch date
Market cap
-
Enterprise valuation
€16—25m (Dealroom.co estimates Mar 2018.)
Knoxville Tennessee (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $400k | Seed | |
| N/A | $600k | Seed | |
$3.4m | Series A | ||
N/A | Debt | ||
$1.4m | Convertible | ||
$4.5m | Early VC | ||
$4.5m | Debt | ||
$800k | Convertible | ||
N/A | Acquisition | ||
| Total Funding | €10.1m | ||
Recent News about Arkis BioSciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.